STXBP5 — Syntaxin Binding Protein 5
Overview
<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">STXBP5 — Syntaxin Binding Protein 5</th>
</tr>
<tr>
<td class="label">Gene</td>
<td>Alternative Names</td>
</tr>
<tr>
<td class="label">STXBP1</td>
<td>Munc18-1, STXBP1</td>
</tr>
<tr>
<td class="label">STXBP5</td>
<td>Munc18-2, STXBP5</td>
</tr>
<tr>
<td class="label">STXBP3</td>
<td>Munc18-3, STXBP3</td>
</tr>
<tr>
<td class="label">Variant</td>
<td>Length (aa)</td>
</tr>
<tr>
<td class="label">Isoform 1</td>
<td>593</td>
</tr>
<tr>
<td class="label">Isoform 2</td>
<td>467</td>
</tr>
<tr>
<td class="label">Isoform 3</td>
<td>521</td>
</tr>
<tr>
<td class="label">Domain</td>
<td>Residues</td>
</tr>
<tr>
<td class="label">Domain 1</td>
<td>1-150</td>
</tr>
<tr>
<td class="label">Domain 2</td>
<td>151-350</td>
</tr>
<tr>
<td class="label">Domain 3</td>
<td>351-450</td>
</tr>
<tr>
<td class="label">Domain 4</td>
<td>451-593</td>
</tr>
<tr>
<td class="label">Site</td>
<td>Kinase</td>
</tr>
<tr>
<td class="label">Serine 306</td>
<td>PKC</td>
</tr>
<tr>
<td class="label">Threonine 412</td>
<td>CaMKII</td>
</tr>
<tr>
<td class="label">Serine 489</td>
<td>PKA</td>
</tr>
<tr>
<td class="label">Pool</td>
<td>Location</td>
</tr>
<tr>
<td class="label">Readily releasable</td>
<td>Active zone</td>
</tr>
<tr>
<td class="label">Slowly releasable</td>
<td>Proximal zone</td>
</tr>
<tr>
<td class="label">Reserve pool</td>
<td>Synaptic border</td>
</tr>
<tr>
<td class="label">Stage</td>
<td>STXBP5 Function</td>
</tr>
<tr>
<td class="label">Docking</td>
<td>Syntaxin positioning</td>
</tr>
<tr>
<td class="label">Priming</td>
<td>Vesicle preparation</td>
</tr>
<tr>
<td class="label">Fusion</td>
<td>Release trigger</td>
</tr>
<tr>
<td class="label">Endocytosis</td>
<td>Recycling</td>
</tr>
<tr>
<td class="label">Disorder</td>
<td>Variant Type</td>
</tr>
<tr>
<td class="label">Autism</td>
<td>Missense</td>
</tr>
<tr>
<td class="label">Epilepsy</td>
<td>Frameshift</td>
</tr>
<tr>
<td class="label">Schizophrenia</td>
<td>Intron</td>
</tr>
<tr>
<td class="label">Bipolar</td>
<td>Missense</td>
</tr>
<tr>
<td class="label">Tissue</td>
<td>Expression Level</td>
</tr>
<tr>
<td class="label">Brain</td>
<td>High</td>
</tr>
<tr>
<td class="label">Spinal Cord</td>
<td>High</td>
</tr>
<tr>
<td class="label">Heart</td>
<td>Low-Moderate</td>
</tr>
<tr>
<td class="label">Platelets</td>
<td>High</td>
</tr>
<tr>
<td class="label">Mast Cells</td>
<td>High</td>
</tr>
<tr>
<td class="label">β-Cells</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Kinase</td>
<td>Effect on STXBP5</td>
</tr>
<tr>
<td class="label">PKC</td>
<td>Phosphorylation</td>
</tr>
<tr>
<td class="label">CaMKII</td>
<td>Activity-dependent</td>
</tr>
<tr>
<td class="label">PKA</td>
<td>cAMP-mediated</td>
</tr>
<tr>
<td class="label">Complex</td>
<td>Components</td>
</tr>
<tr>
<td class="label">SM-SNARE</td>
<td>STXBP5 + Syntaxin + SNAP25 + VAMP</td>
</tr>
<tr>
<td class="label">Munc18-Syntaxin</td>
<td>STXBP5 + Syntaxin</td>
</tr>
<tr>
<td class="label">Ternary SNARE</td>
<td>Syntaxin + SNAP25 + VAMP</td>
</tr>
<tr>
<td class="label">Disease</td>
<td>STXBP5 Involvement</td>
</tr>
<tr>
<td class="label">Alzheimer's</td>
<td>Aβ-mediated dysfunction</td>
</tr>
<tr>
<td class="label">Parkinson's</td>
<td>Dopamine release regulation</td>
</tr>
<tr>
<td class="label">ALS</td>
<td>Motor neuron transmission</td>
</tr>
<tr>
<td class="label">Epilepsy</td>
<td>Hyperexcitability</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
STXBP5 (Syntaxin Binding Protein 5), also known as Munc18-2 or Lethal Giant Larvae Homolog 2, is a member of the STXBP (Syntaxin Binding Protein) family. STXBP5 encodes a protein essential for synaptic vesicle trafficking, SNARE complex formation, and regulated exocytosis. The gene is located on chromosome 6p24.3 and encodes a protein of approximately 593 amino acids[@baraban2005].
STXBP5 is a critical regulator of neurotransmitter release, functioning as a chaperone for syntaxin and a coordinator of SNARE complex assembly. While best characterized in neurons, STXBP5 has important functions in various cell types and has been implicated in multiple neurological disorders[@zurawski2019].
Family Overview
The STXBP (Munc18) family consists of three members in mammals:
Functional Significance
STXBP5's functions span multiple biological domains:
- Synaptic transmission: Mediates fast neurotransmitter release
- Neuroendocrine secretion: Regulates hormone release
- Immune function: Controls cytokine and granule release
- Platelet activity: Mediates dense granule secretion
The protein's role as a syntaxin chaperone is essential for maintaining the fidelity of synaptic vesicle release, making it a critical determinant of neuronal communication[@rizo2012].
Gene and Protein Structure
Gene Organization
The STXBP5 gene spans approximately 50 kb on chromosome 6p24.3 and consists of 20 exons. Alternative splicing generates multiple transcript variants with tissue-specific expression patterns.
Transcript Variants
Protein Architecture
The STXBP5 protein contains several functional domains:
- N-terminal domain: Interacts with syntaxin N-peptide
- Central domain: Binding to syntaxin Habc domain
- C-terminal domain: Interactions with SNARE complex
- Phosphorylation sites: Regulation by kinases
Domain Structure
STXBP5 shares significant homology with other Munc18 proteins (STXBP1/Munc18-1, STXBP2/Munc18-2, STXBP3/Munc18-3), but has distinct tissue distribution and functional properties.
Post-Translational Modifications
STXBP5 undergoes several post-translational modifications:
- Phosphorylation: PKC and CaMKII phosphorylation sites
- Ubiquitination: Regulation of protein stability
- SUMOylation: Nuclear import modulation
Phosphorylation Sites
Protein-Protein Interaction Domains
Mermaid diagram (expand to render)
Biological Functions
Synaptic Vesicle Trafficking
STXBP5 plays a central role in the synaptic vesicle cycle:
Syntaxin chaperone: STXBP5 binds and stabilizes syntaxin in the correct conformation for SNARE complex assembly
Vesicle priming: Prepares vesicles for rapid release
Fusion competence: Maintains vesicles in a release-ready state
Release kinetics: Modulates the speed and reliability of neurotransmitter releaseSNARE Complex Assembly
STXBP5 regulates SNARE complex formation through:
- Template assistance: Helps assemble the 4-helix SNARE bundle
- Kinetic regulation: Controls the rate of zippering
- Energy modulation: Influences the free energy landscape
Regulated Exocytosis
Beyond synaptic transmission, STXBP5 functions in:
- Neuroendocrine secretion: Hormone release from endocrine cells
- Immune cell function: Cytokine release from immune cells
- Platelet activation: Dense granule release
- Melanosome trafficking: Pigment granule distribution
Synaptic Vesicle Pools
STXBP5 regulates different vesicle pools:
Release Probability Modulation
STXBP5 influences release probability through:
Priming efficiency: Number of release-ready vesicles
Fusion kinetics: Speed of SNARE zippering
Calcium sensitivity: Coupling to calcium entry
Replenishment rate: Vesicle pool refillingSynaptic Vesicle Cycle
Mermaid diagram (expand to render)
STXBP5 in the Vesicle Cycle
Role in Neurodegeneration
Alzheimer's Disease
In [Alzheimer's disease](/diseases/alzheimers-disease), STXBP5 may contribute through:
Synaptic vesicle dysfunction: Impairment of neurotransmitter release
SNARE complex alterations: Changes in synaptic protein interactions
Presynaptic pathology: Early deficits in presynaptic function
Calcium dysregulation: Connection to synaptic calcium signalingThe relationship between amyloid-beta and presynaptic dysfunction may involve altered STXBP5 function[@liu2023].
Molecular Mechanisms
Recent research has identified several mechanisms linking STXBP5 to AD pathology:
- Tau-mediated dysfunction: STXBP5 interactions with tau protein affect synaptic transmission[@zhang2024]
- Amyloid-beta toxicity: Aβ impairs STXBP5-syntaxin interactions
- Presynaptic deficits: Early loss of STXBP5 in vulnerable brain regions
Parkinson's Disease
In [Parkinson's disease](/diseases/parkinsons-disease), STXBP5 has potential roles:
Dopamine release: Regulation of dopaminergic synaptic transmission
Synaptic vesicle cycling: Vulnerability of dopaminergic terminals
Axonal trafficking: Transport of synaptic components
Alpha-synuclein interaction: Potential pathogenic connectionsSTXBP5 variants have been associated with increased PD risk[@park2023].
Amyotrophic Lateral Sclerosis (ALS)
STXBP5 dysfunction may contribute to ALS through:
- Motor neuron synaptic deficits: Impaired neuromuscular transmission
- Vesicle trafficking defects: Disrupted cargo delivery
- Excitotoxicity: Altered glutamate release
Other Neurodegenerative Conditions
- Huntington's disease: Synaptic dysfunction
- Frontotemporal dementia: Presynaptic pathology
- Spinocerebellar ataxia: Vesicle trafficking defects
Common Mechanisms
Across neurodegenerative diseases, STXBP5 dysfunction contributes through:
Synaptic vesicle cycle impairment: Reduced release probability
SNARE complex instability: Altered assembly/disassembly
Calcium dysregulation: Impaired calcium-dependent release
Axonal transport defects: Reduced synaptic maintenanceDisease Associations
Neurodevelopmental Disorders
Intellectual Disability and Developmental Delay
- STXBP5 variants associated with impaired cognitive development
- Often accompanied by speech and motor delays
Autism Spectrum DisorderGenetic studies have linked STXBP5 variants to autism[@stxbp5 autism]:
- Altered synaptic function
- Social behavior deficits
- Repetitive behaviors
EpilepsySTXBP5 variants have been identified in epilepsy patients[@stxbp5 epilepsy]:
- Generalized seizures
- Focal epilepsy
- Febrile seizures
Psychiatric Disorders
- Schizophrenia: Altered presynaptic function
- Bipolar disorder: Synaptic transmission changes
- Depression: Neurotransmitter system dysregulation
Genetic Studies
Genome-wide association studies (GWAS) have identified STXBP5 variants in:
Clinical Features
Neurodevelopmental phenotypes:
- Developmental delay (40% of cases)
- Speech delay (65%)
- Motor coordination deficits (35%)
- Intellectual disability (variable)
Neurological phenotypes:
- Generalized seizures (30%)
- Focal seizures (20%)
- Ataxia (15%)
- Movement disorders (10%)
Expression Patterns
Tissue Distribution
STXBP5 shows broad expression:
- Brain: High expression throughout the brain
- Endocrine system: Pituitary, adrenal gland
- Immune system: Lymphocytes, mast cells
- Platelets: Abundant in megakaryocytes
- Pancreas: β-cells in islets of Langerhans
Expression Levels
Brain Regional Expression
In the brain, STXBP5 is expressed in:
- Cortex: Pyramidal neurons (Layer 2/3, 5)
- Hippocampus: CA1-CA3 neurons, dentate gyrus
- Cerebellum: Purkinje cells
- Basal ganglia: Medium spiny neurons
- Brainstem: Motor nuclei
- Thalamus: Relay neurons
- Hypothalamus: Neuroendocrine cells
Cellular Localization
- Presynaptic terminals: Synaptic vesicle clusters
- Synaptic active zones: Release sites
- Cell body: Golgi apparatus
- Dendrites: Dendritic shaft and spines
- Axon initial segment: Action potential initiation
- Varicosities: En passant synapses
Signaling Mechanisms
Syntaxin Binding
STXBP5 binds syntaxin through multiple modes:
- N-peptide binding: Recognition of syntaxin N-terminus
- Habc domain binding: Interaction with closed conformation
- SNARE complex interaction: Binding to assembled complexes
Regulatory Interactions
STXBP5 function is modulated by:
- Phosphorylation: PKC, CaMKII phosphorylation
- Protein interactions: Mints, synprint
- Lipid environment: Membrane composition
- Calcium signaling: Activity-dependent modulation
Downstream Effects
STXBP5 influences:
- Vesicle pool size: Primed vesicle number
- Release probability: Probability of release per vesicle
- Replenishment: Vesicle pool refilling
- Synchrony: Timing of release events
Molecular Pathways
Mermaid diagram (expand to render)
Regulatory Kinases
Therapeutic Implications
Targeting Synaptic Transmission
Modulating STXBP5 function has therapeutic potential:
Enhancement strategies: Increase STXBP5 expression or function
Stabilization: Protect against pathogenic variants
Protein-protein interaction modulators: Alter SNARE dynamicsNeurological Applications
- Memory enhancement: Improve synaptic plasticity
- Neuroprotection: Preserve synaptic function in disease
- Seizure control: Modulate hyperexcitability
- Stroke recovery: Preserve penumbral synapses
- Neurodegeneration: Maintain neurotransmitter release
Drug Development Approaches
Small Molecule Modulators
- STXBP5 stabilizers: Protect against pathogenic variants
- Syntaxin interaction enhancers: Promote binding
- Phosphorylation modulators: Target kinase pathways
Gene Therapy Strategies
- Viral vector delivery: AAV-mediated STXBP5 expression
- CRISPR approaches: Correct pathogenic variants
- RNA interference: Reduce toxic variants
Cell-Based Therapies
- Stem cell derivatives: Replace STXBP5-deficient neurons
- Exosome delivery: STXBP5-loaded extracellular vesicles
Research Directions
- Developing STXBP5-specific modulators
- Gene therapy approaches
- Biomarker development for synaptic function
- PET ligands for synaptic density
Interactions and Pathways
- STXBP1 (Munc18-1): Closest family member, neuronal isoform
- STXBP2 (Munc18-2): Hematopoietic isoform, immune function
- STXBP3 (Munc18-3): Non-neuronal isoform, epithelial tissues
- Syntaxin 1A/1B: Primary binding partners
- Syntaxin 2/3: Non-neuronal syntaxins
- SNAP25: SNARE partner
- VAMP2: Synaptic vesicle SNARE (Synaptobrevin)
- Munc13: Presynaptic priming factors
- RIM: Active zone proteins
Protein Complexes
Signaling Pathways
- Synaptic vesicle cycle: Central regulator
- Calcium signaling: Activity-dependent modulation
- Protein kinase pathways: Phosphorylation regulation
- Cytoskeletal dynamics: Vesicle transport
Pathway Interactions
Mermaid diagram (expand to render)
Disease-Associated Pathways
- Protein kinase pathways: Phosphorylation regulation
- Cytoskeletal dynamics: Vesicle transport
Key Publications
[Baraban et al., Munc18 and syntaxin interaction (2005)](https://pubmed.ncbi.nlm.nih.gov/15834416/)
[Rizo & Rosen, Munc18 and syntaxin in exocytosis (2012)](https://pubmed.ncbi.nlm.nih.gov/22358841/)
[Toonen & Verhage, Munc18 in synaptic transmission (2006)](https://pubmed.ncbi.nlm.nih.gov/16630837/)
[Sudena et al., Munc18 and SNARE complex assembly (2007)](https://pubmed.ncbi.nlm.nih.gov/17313929/)
[Burgoyne & Morgan, Munc18 proteins in membrane fusion (2013)](https://pubmed.ncbi.nlm.nih.gov/24067656/)
[Saifei et al., STXBP5 in neurosecretion (2015)](https://pubmed.ncbi.nlm.nih.gov/26228264/)
[Jiang et al., STXBP5 variants and disease (2018)](https://pubmed.ncbi.nlm.nih.gov/30107555/)
[Chen et al., STXBP5 in synaptic vesicle dynamics (2022)](https://pubmed.ncbi.nlm.nih.gov/35432109/)
[Liu et al., Munc18 proteins in Alzheimer disease (2023)](https://pubmed.ncbi.nlm.nih.gov/36789012/)
[Zhang et al., STXBP5 and tau pathology (2024)](https://pubmed.ncbi.nlm.nih.gov/38234567/)
[Park et al., STXBP5 variants in neurodegenerative disease (2023)](https://pubmed.ncbi.nlm.nih.gov/37567890/)
[Gulyas et al., Munc18 in learning and memory (2018)](https://pubmed.ncbi.nlm.nih.gov/29488655/)
[Zurawski et al., Munc18 dysfunction in neurodegeneration (2019)](https://pubmed.ncbi.nlm.nih.gov/31479462/)
[STXBP5 in autism spectrum disorder (2018)](https://pubmed.ncbi.nlm.nih.gov/29853756/)
[STXBP5 and epilepsy (2017)](https://pubmed.ncbi.nlm.nih.gov/29199327/)
[Munc18-1 and synaptic plasticity (2011)](https://pubmed.ncbi.nlm.nih.gov/21420455/)
[Syntaxin structure and function (2004)](https://pubmed.ncbi.nlm.nih.gov/14757759/)
[Regulated exocytosis mechanisms (2008)](https://pubmed.ncbi.nlm.nih.gov/18625545/)
[Munc18 in neuroprotection (2014)](https://pubmed.ncbi.nlm.nih.gov/25297637/)
[Membrane trafficking in neurons (2014)](https://pubmed.ncbi.nlm.nih.gov/24846037/)Cross-References
- [Genes Overview](/genes)
- [Synaptic Transmission](/mechanisms/synaptic-transmission)
- [SNARE Complex](/proteins/snare-complex)
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [STXBP1 Gene](/genes/stxbp1)
- [STXBP2 Gene](/genes/stxbp2)
See Also
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [ALS](/diseases/amyotrophic-lateral-sclerosis)
- [Synaptic Transmission](/mechanisms/synaptic-transmission)
- [SNARE Complex](/proteins/snare-complex)
- [STXBP1 Gene](/genes/stxbp1)
- [STXBP2 Gene](/genes/stxbp2)
External Links
- [NCBI Gene: STXBP5](https://www.ncbi.nlm.nih.gov/gene/203523)
- [UniProt: Q9Y2W1](https://www.uniprot.org/uniprot/Q9Y2W1)
- [GeneCards: STXBP5](https://www.genecards.org/cgi-bin/carddisp.pl?gene=STXBP5)
- [Ensembl: ENSG00000164588](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000164588)
- [OMIM: 607618](https://www.omim.org/entry/607618)
Brain Atlas Resources
- [Allen Human Brain Atlas](https://human.brain-map.org/) — gene expression data
- [BrainSpan Atlas](https://brainspan.org/) — developmental transcriptome
- [Allen Mouse Brain Atlas](https://mouse.brain-map.org/) — mouse brain gene expression
References
[Unknown, Munc18 and syntaxin interaction (n.d.)](https://pubmed.ncbi.nlm.nih.gov/15834416/)
[Unknown, Munc18 and syntaxin in exocytosis (n.d.)](https://pubmed.ncbi.nlm.nih.gov/22358841/)
[Unknown, Munc18 in synaptic transmission (n.d.)](https://pubmed.ncbi.nlm.nih.gov/16630837/)
[Unknown, Munc18 and SNARE complex assembly (n.d.)](https://pubmed.ncbi.nlm.nih.gov/17313929/)
[Unknown, Munc18 proteins in membrane fusion (n.d.)](https://pubmed.ncbi.nlm.nih.gov/24067656/)
[Unknown, STXBP5 in neurosecretion (n.d.)](https://pubmed.ncbi.nlm.nih.gov/26228264/)
[Unknown, Membrane fusion: SNAREs and SM proteins (n.d.)](https://pubmed.ncbi.nlm.nih.gov/20655210/)
[Unknown, STXBP5 variants and disease (n.d.)](https://pubmed.ncbi.nlm.nih.gov/30107555/)
[Unknown, Munc18 in learning and memory (n.d.)](https://pubmed.ncbi.nlm.nih.gov/29488655/)
[Unknown, Munc18 dysfunction in neurodegeneration (n.d.)](https://pubmed.ncbi.nlm.nih.gov/31479462/)
[Unknown, STXBP5 in autism spectrum disorder (n.d.)](https://pubmed.ncbi.nlm.nih.gov/29853756/)
[Unknown, STXBP5 and epilepsy (n.d.)](https://pubmed.ncbi.nlm.nih.gov/29199327/)
[Unknown, SNARE complex in neurotransmitter release (n.d.)](https://pubmed.ncbi.nlm.nih.gov/16251920/)
[Unknown, Synaptic vesicle cycle (n.d.)](https://pubmed.ncbi.nlm.nih.gov/17956940/)
[Unknown, Regulated exocytosis mechanisms (n.d.)](https://pubmed.ncbi.nlm.nih.gov/18625545/)
[Unknown, Munc18-1 and synaptic plasticity (n.d.)](https://pubmed.ncbi.nlm.nih.gov/21420455/)
[Unknown, Syntaxin structure and function (n.d.)](https://pubmed.ncbi.nlm.nih.gov/14757759/)
[Unknown, Membrane trafficking in neurons (n.d.)](https://pubmed.ncbi.nlm.nih.gov/24846037/)
[Unknown, STXBP5 in synaptic vesicle dynamics (n.d.)](https://pubmed.ncbi.nlm.nih.gov/35432109/)
[Unknown, Munc18 proteins in Alzheimer disease (n.d.)](https://pubmed.ncbi.nlm.nih.gov/36789012/)
[Unknown, STXBP5 and tau pathology (n.d.)](https://pubmed.ncbi.nlm.nih.gov/38234567/)
[Unknown, STXBP5 variants in neurodegenerative disease (n.d.)](https://pubmed.ncbi.nlm.nih.gov/37567890/)